Synaptopathies: synaptic dysfunction in neurological disorders–A review from students to students K Lepeta, MV Lourenco, BC Schweitzer, PV Martino Adami, P Banerjee, ... Journal of neurochemistry 138 (6), 785-805, 2016 | 309 | 2016 |
N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington's disease DJ Wright, T Renoir, ZM Smith, AE Frazier, PS Francis, DR Thorburn, ... Translational psychiatry 5 (1), e492-e492, 2015 | 125 | 2015 |
Analysis of 153 deaths after upper gastrointestinal endoscopy: room for improvement? AM Thompson, DJ Wright, W Murray, GL Ritchie, HD Burton, ... Surgical Endoscopy And Other Interventional Techniques 18, 22-25, 2004 | 104 | 2004 |
N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington’s disease DJ Wright, LJ Gray, DI Finkelstein, PJ Crouch, D Pow, TY Pang, S Li, ... Human molecular genetics 25 (14), 2923-2933, 2016 | 50 | 2016 |
The influence of the HPG axis on stress response and depressive-like behaviour in a transgenic mouse model of Huntington's disease X Du, TY Pang, C Mo, T Renoir, DJ Wright, AJ Hannan Experimental neurology 263, 63-71, 2015 | 34 | 2015 |
Enhancing permanganate chemiluminescence detection for the determination of glutathione and glutathione disulfide in biological matrices ZM Smith, JM Terry, NW Barnett, LJ Gray, DJ Wright, PS Francis Analyst 139 (10), 2416-2422, 2014 | 25 | 2014 |
Huntington’s Disease: Pathogenic mechanisms and therapeutic targets DJ Wright, T Renoir, LJ Gray, AJ Hannan Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic …, 2017 | 10 | 2017 |
Evaluating the attitudes of mental health professionals towards trials of MDMA: a randomised vignette trial DJ Wright, B Colagiuri, N Glozier BMJ open 12 (11), e060360, 2022 | 2 | 2022 |
Implementation of a ketamine programme for treatment-resistant depression in the public health system: Lessons from the first Australian public hospital clinic NLR Thornton, DJ Wright, N Glozier Australian & New Zealand Journal of Psychiatry, 00048674241237094, 2024 | | 2024 |
Die Kraftwerke der Zellen-über die Behandlung von psychiatrischen Symptomen bei Patienten mit Mitochondriopathien S Mörkl, A Tmava, C Blesl, F Schmiedhofer, WE Wurm, A Holl, A Painold Fortschritte der Neurologie· Psychiatrie 85 (08), 474-478, 2017 | | 2017 |
N-ACETYLCYSTEINE (NAC) IN HUNTINGTON’S DISEASE (HD) AND AFFECTIVE-LIKE DISORDERS D Wright, T Renoir, L Gray, A Hannan Journal of International Society of Antioxidants in Nutrition & Health 1 (1), 2016 | | 2016 |
Synaptopathies: synaptic dysfunction in neurological disorders-A review written by students for students K Lepeta, MV Lourenco, BC Schweitzer, PV Martino Adami, P Banerjee, ... Wiley Blackwell Publishing, Inc, 2016 | | 2016 |
Environmental and pharmacological modulation of molecular pathogenesis in Huntington's disease T Renoir, DJ Wright, LJ Gray, DI Finkelstein, PJ Crouch, D Pow, T Pang, ... Conference Abstract: 14 th Meeting of the Asian-Pacific Society for …, 2016 | | 2016 |
The therapeutic effects of N-acetylcysteine in a mouse model of Huntington’s disease D Wright University of Melbourne, 2016 | | 2016 |
Molecular mediators, environmental modulators and gene-environment interactions in huntington's disease A Hannan, C Mo, D Wright, X Du, T Pang, P Crouch, J Nithianantharajah, ... Deakin University, 2015 | | 2015 |
Therapeutic potential of n-acetylcysteine in huntington's disease: effects on glutamate uptake and mitochondrial function in mice D Wright, T Renoir, D Finkelstein, D Thorburn, P Francis, S McGee, L Gray, ... Proceedings of the 25th Biennial Meeting of the International Society for …, 2015 | | 2015 |
CALCULATING THE PROTAMINE HEPARINE REVERSAL RATIO WB Murray, WA Hampton, H Hargovan, D Wright The Journal of the American Society of Anesthesiologists 75 (3), A62-A62, 1991 | | 1991 |